OPTN (Option Therapeutics) Goodwill-to-Asset: 0.29 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Option Therapeutics Goodwill-to-Asset?

Option Therapeutics OPTN Goodwill-to-Asset is 0.29 as of Dec. 2025.

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets. Option Therapeutics's Goodwill for the quarter that ended in Dec. 2025 was $0.35 Mil. Option Therapeutics's Total Assets for the quarter that ended in Dec. 2025 was $1.21 Mil.

Option Therapeutics  (AMEX:OPTN) Goodwill-to-Asset Explanation

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.

Option Therapeutics Goodwill-to-Asset Related Terms

Option Therapeutics Goodwill-to-Asset Historical Data

* Premium members only.

The historical data trend for Option Therapeutics's Goodwill-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Option Therapeutics Goodwill-to-Asset Chart

Option Therapeutics Annual Data
Trend Jun24 Jun25
Goodwill-to-Asset
0.42 0.34

Option Therapeutics Quarterly Data
Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Goodwill-to-Asset Get a 7-Day Free Trial 0.00 0.00 0.34 0.31 0.29

OPTN vs : Goodwill-to-Asset Comparison

For the Biotechnology subindustry, Option Therapeutics's Goodwill-to-Asset, along with its competitors' market caps and Goodwill-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Option Therapeutics Goodwill-to-Asset vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Option Therapeutics's Goodwill-to-Asset distribution charts can be found below:

* The bar in red indicates where Option Therapeutics's Goodwill-to-Asset falls into.


Option Therapeutics Goodwill-to-Asset Calculation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

Option Therapeutics's Goodwill to Asset Ratio for the fiscal year that ended in Jun. 2025 is calculated as

Goodwill to Asset (A: Jun. 2025 )=Goodwill/Total Assets
=0.346/1.017
=

Option Therapeutics's Goodwill to Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

Goodwill to Asset (Q: Dec. 2025 )=Goodwill/Total Assets
=0.346/1.206
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Goodwill-to-Asset →
What does a Goodwill-to-Asset of 0.29 mean?
Option Therapeutics (OPTN) has a Goodwill-to-Asset of 0.29 as of Dec. 2025. Goodwill-to-Asset Ratio is the total goodwill from acquisitions divided by total assets. View historical data on Option Therapeutics and its competitors.
Is Option Therapeutics' Goodwill-to-Asset too high?
Option Therapeutics' current Goodwill-to-Asset is 0.29.
How does Option Therapeutics' Goodwill-to-Asset compare to ?
Option Therapeutics' Goodwill-to-Asset of 0.29 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Goodwill-to-Asset for a Biotechnology company?
A good Goodwill-to-Asset depends on the Biotechnology industry context. However, Goodwill-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Goodwill-to-Asset mean?
A high Goodwill-to-Asset can signal that a stock is expensive relative to its fundamentals. Goodwill-to-Asset Ratio is the total goodwill from acquisitions divided by total assets. View historical data on Option Therapeutics and its competitors. Option Therapeutics's current Goodwill-to-Asset is 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Option Therapeutics stock overvalued right now?
Option Therapeutics (OPTN) has a current Goodwill-to-Asset of 0.29. The current Goodwill-to-Asset is 0.29. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Goodwill-to-Asset calculated?
Goodwill-to-Asset is calculated from a company's financial statements. For Option Therapeutics (OPTN), the current Goodwill-to-Asset is 0.29 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Option Therapeutics Business Description

Comparable Companies
Address 680 West Nye Lane, Suite 201, Carson, NV, USA, 89703
Option Therapeutics Inc is a clinical-stage company developing inventive drug therapies to treat debilitating and life-threatening liver disease through its investigational drug candidate BIV201 (continuous infusion terlipressin). BIV201 is administered as a patent-pending liquid formulation of terlipressin with patents issued, to date, in the U.S., China, Japan, Chile, and India.